Weakness Seen in AngioDynamics (ANGO): Stock Tumbles 7.8% - Tale of the Tape

AngioDynamics Inc. ANGO saw a big move last session, as the company's shares fell nearly 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ANGO, as the stock is now down nearly 17% in the past one-month time frame.

This slump shouldn't be too much of a surprise to investors, as the medical instruments provider has seen 3 negative revisions in the past few weeks and its current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

ANGO currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same sector include Delcath Systems, Inc. DCTH, Syneron Medical Ltd. ELOS and Cyberonics Inc. CYBX. While Delcath and Syneron sport a Zacks Rank #1 (Strong Buy), Cyberonics holds a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

 

 
ANGIODYNAMICS ANGO: Free Stock Analysis Report
 
CYBERONICS INC CYBX: Free Stock Analysis Report
 
DELCATH SYS INC DCTH: Free Stock Analysis Report
 
SYNERON MED LTD ELOS: Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!